PubRank

Takeru Makiyama

Author PubWeight™ 50.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J Am Coll Cardiol 2009 2.12
2 Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study. Heart Rhythm 2010 2.00
3 Clinical impact of left ventricular outflow tract obstruction in takotsubo cardiomyopathy. Circ J 2015 1.95
4 High prevalence of early repolarization in short QT syndrome. Heart Rhythm 2010 1.87
5 Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization. Circ Arrhythm Electrophysiol 2011 1.74
6 A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents. Cardiovasc Res 2011 1.70
7 The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest 2008 1.69
8 Novel SCN3B mutation associated with brugada syndrome affects intracellular trafficking and function of Nav1.5. Circ J 2012 1.52
9 Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan. Circ J 2013 1.50
10 Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome. J Cardiovasc Electrophysiol 2008 1.50
11 Clinical and electrocardiographic characteristics of patients with short QT interval in a large hospital-based population. Heart Rhythm 2011 1.45
12 L-type calcium channel mutations in Japanese patients with inherited arrhythmias. Circ J 2013 1.44
13 Risk determinants in individuals with a spontaneous type 1 Brugada ECG. Circ J 2011 1.44
14 Pediatric Cohort With Long QT Syndrome　- KCNH2 Mutation Carriers Present Late Onset But Severe Symptoms. Circ J 2016 1.40
15 Atrioventricular block-induced Torsades de Pointes with clinical and molecular backgrounds similar to congenital long QT syndrome. Circ J 2010 1.39
16 Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome. Circ Arrhythm Electrophysiol 2009 1.33
17 Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J 2013 1.11
18 Phenotype variability in patients carrying KCNJ2 mutations. Circ Cardiovasc Genet 2012 1.09
19 KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation. Circ Arrhythm Electrophysiol 2011 1.01
20 Mechanistic basis for the pathogenesis of long QT syndrome associated with a common splicing mutation in KCNQ1 gene. J Mol Cell Cardiol 2007 1.01
21 Mutation site dependent variability of cardiac events in Japanese LQT2 form of congenital long-QT syndrome. Circ J 2008 0.99
22 Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome. Hum Mutat 2009 0.95
23 Long-term follow-up of a pediatric cohort with short QT syndrome. J Am Coll Cardiol 2013 0.94
24 Impact of CYP2C19 polymorphisms on the antiplatelet effect of clopidogrel in an actual clinical setting in Japan. Circ J 2009 0.94
25 A connexin40 mutation associated with a malignant variant of progressive familial heart block type I. Circ Arrhythm Electrophysiol 2012 0.91
26 Gain-of-function KCNH2 mutations in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2014 0.88
27 Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome. Hum Mutat 2007 0.88
28 The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging. Cardiovasc Res 2009 0.88
29 Identification and functional characterization of KCNQ1 mutations around the exon 7-intron 7 junction affecting the splicing process. Biochim Biophys Acta 2011 0.86
30 N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome. Heart Rhythm 2006 0.85
31 Age-dependent clinical and genetic characteristics in Japanese patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ J 2013 0.85
32 Additional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome. J Cardiovasc Electrophysiol 2004 0.82
33 Percutaneous balloon valvuloplasty for bioprosthetic mitral valve stenosis. Heart Vessels 2012 0.82
34 Effects of PPIs and an H2 blocker on the antiplatelet function of clopidogrel in Japanese patients under dual antiplatelet therapy. J Atheroscler Thromb 2012 0.81
35 A novel HCN4 mutation, G1097W, is associated with atrioventricular block. Circ J 2014 0.79
36 Double SCN5A mutation underlying asymptomatic Brugada syndrome. Heart Rhythm 2005 0.79
37 Blockade of angiotensin II type 1 receptor improves the arrhythmia morbidity in mice with left ventricular hypertrophy. Circ J 2006 0.79
38 Prediction of clopidogrel low responders by a rapid CYP2C19 activity test. J Atheroscler Thromb 2011 0.78
39 WTC deafness Kyoto (dfk): a rat model for extensive investigations of Kcnq1 functions. Physiol Genomics 2005 0.78
40 Clinical characteristics and risk of arrhythmia recurrences in patients with idiopathic ventricular fibrillation associated with early repolarization. Int J Cardiol 2012 0.77
41 Cardiac channelopathies associated with infantile fatal ventricular arrhythmias: from the cradle to the bench. J Cardiovasc Electrophysiol 2013 0.77
42 A novel SCN5A mutation demonstrating a variety of clinical phenotypes in familial sick sinus syndrome. Intern Med 2012 0.77
43 Heart rate-dependent variability of cardiac events in type 2 congenital long-QT syndrome. Europace 2010 0.77
44 A novel SCN5A mutation associated with the linker between III and IV domains of Nav1.5 in a neonate with fatal long QT syndrome. Int J Cardiol 2009 0.76
45 A novel mutation associated with Jervell and Lange-Nielsen syndrome in a Japanese family. Circ J 2008 0.76
46 Dynamic change in ST-segment and spontaneous occurrence of ventricular fibrillation in Brugada syndrome with a novel nonsense mutation in the SCN5A gene during long-term follow-up. Circ J 2008 0.75
47 Phenotypic Variability of ANK2 Mutations in Patients With Inherited Primary Arrhythmia Syndromes. Circ J 2016 0.75
48 Long-term clinical outcomes after sirolimus-eluting stent implantation for unprotected left main coronary artery disease. Cardiovasc Interv Ther 2014 0.75
49 A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome. Circ Cardiovasc Genet 2011 0.75
50 Long-term efficacy and safety outcomes after unrestricted use of drug-eluting stents in patients with acute coronary syndrome: mortality and major bleeding in a single-center registry. Circ J 2014 0.75
51 [Severe arrythmic events triggered by fever in a case of Brugada syndrome]. Nihon Naika Gakkai Zasshi 2007 0.75
52 Early-onset Atrial Fibrillation in Brothers with a Huge Left Atrial Appendage. Intern Med 2016 0.75